News

Fierce Healthcare3d
Hims & Hers' Q1 revenue doubles to $586M, boosted by growth in weight loss business
But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...
Healio7d
GLP-1 agents ‘can help lower systemic inflammation,’ show promise in rheumatology
The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...
Medical Dialogues3d
WHO to back use of weight-loss drugs as obesity treatment in adults
London: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity ...
WHO set to back use of weight-loss drugs for adults globally, raises cost issue
LONDON - The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for ...
Novo Nordisk teams with telehealth firms Him, Ro to sell Wegovy at lower price
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
Exclusive-WHO to back use of weight-loss drugs for adults globally, raises cost issue
LONDON (Reuters) -The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in ...